Novonix Limited
NVNXF
$0.27
$0.00552.08%
Weiss Ratings | NVNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | NVNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Very Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | NVNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.88 | |||
Price History | NVNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -10.03% | |||
30-Day Total Return | -32.50% | |||
60-Day Total Return | -38.29% | |||
90-Day Total Return | -47.06% | |||
Year to Date Total Return | -43.18% | |||
1-Year Total Return | -57.14% | |||
2-Year Total Return | -72.88% | |||
3-Year Total Return | -92.24% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -66.42% | |||
52-Week Low % Change | 19.14% | |||
Price | NVNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.79 | |||
52-Week Low Price | $0.22 | |||
52-Week Low Price (Date) | Mar 05, 2025 | |||
52-Week High Price (Date) | Apr 11, 2024 | |||
Valuation | NVNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 166.27M | |||
Enterprise Value | 195.72M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.15 | |||
Earnings Per Share Growth | 55.76% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 23.00 | |||
Price/Book (Q) | 1.09 | |||
Enterprise Value/Revenue (TTM) | 33.43 | |||
Price | $0.27 | |||
Enterprise Value/EBITDA (TTM) | -3.88 | |||
Enterprise Value/EBIT | -3.60 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | NVNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 504.84M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | NVNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 61 4 3931 0818 | |||
Address | 71 Eagle Street Brisbane, QLD 4000 | |||
Website | www.novonixgroup.com | |||
Country | Australia | |||
Year Founded | 2012 | |||
Profitability | NVNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -929.39% | |||
Profit Margin | -1,278.05% | |||
Management Effectiveness | NVNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -13.90% | |||
Return on Equity | -- | |||
Income Statement | NVNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 5.85M | |||
Total Revenue (TTM) | 5.85M | |||
Revenue Per Share | $0.01 | |||
Gross Profit (TTM) | 4.08M | |||
EBITDA (TTM) | -50.46M | |||
EBIT (TTM) | -54.41M | |||
Net Income (TTM) | -74.82M | |||
Net Income Avl. to Common (TTM) | -74.82M | |||
Total Revenue Growth (Q YOY) | -24.68% | |||
Earnings Growth (Q YOY) | -154.06% | |||
EPS Diluted (TTM) | -0.15 | |||
EPS Diluted Growth (Q YOY) | -145.70% | |||
Balance Sheet | NVNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 42.56M | |||
Cash Per Share (Q) | $0.08 | |||
Total Current Assets (Q) | 57.30M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 137.59M | |||
Current Ratio (Q) | 1.239 | |||
Book Value Per Share (Q) | $0.24 | |||
Total Assets (Q) | 226.10M | |||
Total Current Liabilities (Q) | 46.24M | |||
Total Debt (Q) | 71.45M | |||
Total Liabilities (Q) | 88.51M | |||
Total Common Equity (Q) | 137.59M | |||
Cash Flow | NVNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -18.17M | |||
Cash from Financing (TTM) | 25.21M | |||
Net Change in Cash (TTM) | -36.16M | |||
Levered Free Cash Flow (TTM) | -52.44M | |||
Cash from Operations (TTM) | -40.42M | |||